Intellectual Property India Publishes Patent Application for 'Detection Of Tumor-Derived Nucleic Acids Using Red Blood Cells' Filed by The Trustees Of The University Of Pennsylvania

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202517121201 A) filed by The Trustees Of The University Of Pennsylvania, Philadelphia, on Dec. 3, 2025, for 'detection of tumor-derived nucleic acids using red blood cells.'

Inventor(s) include Mangalmurti, Nilam; and Thompson, Jeffrey.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "Described herein are methods of diagnosing a cancer in a subject. The method includes contacting a red blood cell-containing sample from the subject with a reagent capable of detecting a tumor-associated molecule in the sample; and diagnosing the subject with a tumor when the tumor-associated molecule is detected in the sample. In some embodiments, suitable samples are less than 10 L."

The patent application was internationally filed on May 06, 2024, under International application No.PCT/US2024/028028.

Disclaimer: Curated by HT Syndication.